Welcome to the e-CCO Library!

P392: Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis, healthy stool donors and the general Australian population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Costello S.*1,2,3, Mashei C.3, Bryant R.2,3, Katsikeros R.3, Waters O.4, Makanyanga J.4, Hughes P.2, Conlon M.5, Roberts-Thomson I.1,2, Andrews J.2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P392: Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn’s disease: A prospective cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Ben-Horin1*, A. Lahat1, M.M. Amitai2, E. Klang2, D. Yablecovitch1, S. Neuman1, N. Levhar1, L. Selinger1, M. Bubis1, O. Picard1, D. Turner3, S. Odes4, H. Yanai5, Y. Chowers6, I. Dotan5, U. Kopylov1, R. Eliakim1

Created: Thursday, 21 February 2019, 9:14 AM
P392: Risk factors for postoperative recurrence after ileocolic resection for Crohn's Disease: long-term results from a population-based cohort.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: van Renterghem, A.(1)*;van der Holst, A.(1);van Kuijk, S.(2);Pierik, M.(3);Belgers, E.(4);Romberg-Camps, M.(5);Jeuring, S.(3);Demandt, D.(1);Stassen, L.(1);
Created: Friday, 14 July 2023, 11:05 AM
P392: To study the prevalence of depression and anxiety in patients of Inflammatory Bowel Disease (IBD) and the efficacy of psychopharmacotherapy in these patients: A pilot study
Year: 2022
Source: ECCO'22
Authors: Patel, A.(1);Joshi, H.(1);Wagh, A.(1);Bhatt, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P393 Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Afzali1, A. Armuzzi2, Y. Bouhnik3, B. Bressler4, A. Hart5, D. Rubin6, M. Sans7, B. Siegmund8, D. Sninsky9

Created: Thursday, 30 January 2020, 10:12 AM
P393: Effect of filgotinib on anaemia in patients with Ulcerative Colitis in SELECTION
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Loveikyte, R.(1)*;de Haas, A.(2);Oortwijn, A.(3);Eskens, B.(3);Jamoul, C.(4);Muller, K.(4);van der Meulen-de Jong, A.(5);
Created: Friday, 14 July 2023, 11:05 AM
P393: Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis.
Year: 2022
Source: ECCO'22
Authors: Veyrard, P.(1);Pellet, G.(2);Laharie, D.(2);Nachury, M.(3);juillerat, P.(4);Altwegg, R.(5);Nancey, S.(6);Fumery, M.(7);Allez, M.(8);Tran minh, M.L.(9);Roblin, X.(10);
Created: Friday, 11 February 2022, 3:52 PM
P393: Evaluation of pharmacokinetic profiles of SB2 as a biosimilar of reference infliximab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shin D., Kang J.W., Park S., Lee Y., Lee S.

Created: Wednesday, 20 February 2019, 10:36 AM
P393: Investigation of Crohn’s disease patients receiving anti-TNF α therapy after surgery for intestinal stenosis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Kuriyama*, B. Iizuka, H. Kashiwagi, T. Hara, A. Ito, T. Omori, M. Yonezawa, K. Tokushige

Created: Friday, 22 February 2019, 9:49 AM
P393: Long-term prediction of infliximab response using CD-62L shedding assay: Longitudinal data from 5-year study in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Macpherson1, F. Bravo2, P. Andrew1, E. Slack1, N. Patuto1, J. Cahenzli1, K.D. McCoy1, A.J. Macpherson2, P. Juillerat1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P393: Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on infliximab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Yerlioglu*1, L. Cococcioni1, A. ElZein1, S. Sider1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM
P393: Treatment patterns of patients with perianal fistulizing Crohn’s disease from a US administrative claims database
Year: 2021
Source: ECCO'21 Virtual
Authors: Cazzetta, S.(1);Chen, G.(2);Pedarla, V.(3);Null, K.(4);Rana Khan, Q.(1);Schwartz, D.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P394 Preoperative factors associated with prolonged postoperative in-hospital length of stay in patients with Crohn’s disease undergoing intestinal resection or strictureplasty
Year: 2020
Source:

ECCO'20 Vienna

Authors:

T. Vinh Luong1, S. Dich Grandt2, I. Negoi3, S. Palubinskas2, A. El-Hussuna2

Created: Thursday, 30 January 2020, 10:12 AM
P394: A prospective analysis of body composition in patients with Inflammatory Bowel Disease and changes during biologic therapy
Year: 2022
Source: ECCO'22
Authors: Nguyen, A.(1);Burns, M.(2);Herath, M.(3);Holt, D.(2);Gibson, P.R.(4);Milat, F.(3);Ebeling, P.(5);Moore, G.(6);
Created: Friday, 11 February 2022, 3:52 PM
P394: Contribution of the CDEIS in the new therapeutic approach of Crohn's disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Sabbek*1, N. Elleuch2, A. Ben Slama2, E. Hammami2, H. Jaziri2, A. Braham2, S. Ajmi2, M. Ksiaa2, A. Jmaa2

Created: Friday, 22 February 2019, 9:41 AM
P394: Long-term perineal reoperation and wound healing after proctectomy or ileal pouch-anal anastomosis extirpation in patients with Inflammatory Bowel Disease – a retrospective multicentre study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Berghog, J.(1)*;Hermansson, M.(2);Risto, A.(3);Strömbäck, J.(4);Unger, D.(4);Gustafsson, H.(5);Hagavall, M.(6);Landerholm, K.(7);Buchwald, P.(8);Nordenvall, C.(9);Myrelid, P.(3);Block, M.(2);
Created: Friday, 14 July 2023, 11:05 AM
P394: Preoperative serum vedolizumab levels do not predict postoperative outcomes in inflammatory bowel disease (IBD)
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Lopez1, K. Zaghiyan1, G. Melmed1, D. McGovern1, A. Jain2, S. Targan1, P. Fleshner1*, C. Landers1

Created: Thursday, 21 February 2019, 9:14 AM
P394: Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Qiu Y.*1, Mao R.1, Zhang S.-h.2, Feng R.2, Zeng Z.-r.1, Chen M.-h.2

Created: Wednesday, 20 February 2019, 10:36 AM
P394: Psychosexual dysfunction in a cohort of Greek inflammatory bowel disease patients in clinical remission: preliminary results
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Xanthis*, K. Soufleris, E. Gavalas, P. Anyfanti, G. Chatzinakos, N. Grammatikos, A. Tsimperidis, O. Giouleme

Created: Friday, 22 February 2019, 9:49 AM